Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

10.36 -0.32 (-3.03%)
Streaming Delayed Price Updated: 10:14 AM EDT, May 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Bioventus Inc (NASDAQ:BVS) Smashes Q1 Estimates and Lifts Guidance, Shares Rally ↗
Via Chartmill
News headline image
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Inc (NASDAQ:BVS) Reports Q4 Earnings Beat and Strong 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Examining the Future: Bioventus's Earnings Outlook ↗
 
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Bioventus (BVS) Q4 2025 Earnings Call Transcript ↗
Bioventus (BVS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
These stocks are gapping in today's session ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Bioventus Inc (NASDAQ:BVS) Reports Q3 2025 Earnings Beat and Strong Profitability Growth ↗
Bioventus (BVS) reported strong Q3 2025 earnings, beating EPS estimates with a 200% surge. While revenue slightly missed, organic growth was up 8.2%. 
Via Chartmill
Topics Earnings
News headline image
Bioventus Reports Third Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Inc. (NASDAQ:BVS) Reports Mixed Q2 2025 Earnings Amid Muted Market Reaction ↗
Bioventus Inc. (BVS) reports mixed Q2 2025 results with slight revenue miss but EPS near estimates. Organic growth up 6.2%, yet stock dips 2% pre-market. 
Via Chartmill
News headline image
Bioventus Reports Second Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
From Bioventus, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.